Building a Pipeline of Therapies to Treat Rare Mineralization Disorders

RARECast - Ein Podcast von RARECast - Donnerstags

Podimo 45 Tage kostenlos testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

Werbung

Kategorien:

Wirtschaft

Axel Bolte, co-founder and CEO of Inozyme, discusses ENPP1 deficiency, the company's lead experimental therapy to treat the condition, and its work with Rady Children’s Institute for Genomic Medicine to improve the diagnosis of newborns with the disease.

Visit the podcast's native language site